|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,485.65 INR | +1.25% |
|
+2.06% | +0.59% |
| Market Cap | 421B 4.37B 3.83B 3.54B 3.25B 6.14B 6.24B 42.3B 16.58B 206B 16.4B 16.04B 710B | P/E 2027 * |
36.6x | P/E 2028 * | 32.5x |
|---|---|---|---|---|---|
| Enterprise Value | 421B 4.37B 3.83B 3.54B 3.25B 6.14B 6.24B 42.3B 16.58B 206B 16.4B 16.04B 710B | EV / Sales 2027 * |
10x | EV / Sales 2028 * | 9.06x |
| Free-Float |
24.37% | Yield 2027 * |
1.19% | Yield 2028 * | 1.19% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +1.25% | ||
| 1 week | +2.06% | ||
| Current month | +1.42% | ||
| 1 month | +6.55% | ||
| 3 months | +1.38% | ||
| 6 months | +6.70% | ||
| Current year | +0.59% |
| 1 week | 2,412.55 |  | 2,525 |
| 1 month | 2,320.7 | | 2,525 |
| Current year | 2,088 | | 2,715.15 |
| 1 year | 2,088 | | 3,217.1 |
| 3 years | 1,376.5 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 2022-11-30 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 2026-03-31 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Subesh Williams
BRD | Director/Board Member | 64 | 2017-04-06 |
Renu Sud Karnad
CHM | Chairman | 73 | 2019-03-31 |
| Director/Board Member | 59 | 2020-05-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.25% | +2.06% | -20.95% | +77.28% | 4.32B | |
| -2.11% | -1.59% | +52.60% | +150.76% | 1,051B | |
| -1.51% | -3.05% | +52.04% | +48.41% | 609B | |
| -0.32% | +2.11% | +36.99% | +78.09% | 450B | |
| -0.75% | +0.30% | +29.77% | +21.15% | 330B | |
| -1.52% | -1.19% | +34.46% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.99% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.18% | -40.59% | 223B | |
| -0.40% | +1.34% | +23.46% | +56.62% | 198B | |
| -0.80% | +1.69% | +23.40% | +67.14% | 167B | |
| Average | -0.75% | +0.57% | +23.26% | +51.00% | 357.94B | |
| Weighted average by Cap. | -1.15% | +0.02% | +37.08% | +72.06% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 41.99B 435M 382M 353M 324M 612M 622M 4.22B 1.65B 20.54B 1.64B 1.6B 70.78B | 46.49B 482M 423M 391M 359M 678M 689M 4.67B 1.83B 22.75B 1.81B 1.77B 78.37B |
| Net income | 11.42B 118M 104M 95.93M 88.22M 166M 169M 1.15B 450M 5.59B 445M 435M 19.25B | 12.54B 130M 114M 105M 96.92M 183M 186M 1.26B 494M 6.14B 488M 478M 21.14B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | ₹2,485.65 | +1.25% | 5,238 |
| 26-07-17 | ₹2,455.05 | -2.06% | 3,304 |
| 26-07-16 | ₹2,506.70 | +0.85% | 3,034 |
| 26-07-15 | ₹2,485.65 | +0.90% | 4,764 |
| 26-07-14 | ₹2,463.55 | +1.91% | 9,059 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
